(Q43865308)

English

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

author name string

Michael Davidson

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Patrick Ma

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Evan A Stein

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Antonio M Gotto

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ali Raza

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Rohini Chitra

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Howard Hutchinson

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

268-275

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

Drug treatment of lipid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

Prospective evaluation of a stiff shaft glide wire compared with the standard straight wire in crossing severely stenotic aortic valves

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902226-3

7 January 2021

Identifiers

10.1016/S0002-9149(01)02226-3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43865308&oldid=2104012025"